α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease
Overview
Authors
Affiliations
Participation of the small, intrinsically disordered protein α-synuclein (α-syn) in Parkinson disease (PD) pathogenesis has been well documented. Although recent research demonstrates the involvement of α-syn in mitochondrial dysfunction in neurodegeneration and suggests direct interaction of α-syn with mitochondria, the molecular mechanism(s) of α-syn toxicity and its effect on neuronal mitochondria remain vague. Here we report that at nanomolar concentrations, α-syn reversibly blocks the voltage-dependent anion channel (VDAC), the major channel of the mitochondrial outer membrane that controls most of the metabolite fluxes in and out of the mitochondria. Detailed analysis of the blockage kinetics of VDAC reconstituted into planar lipid membranes suggests that α-syn is able to translocate through the channel and thus target complexes of the mitochondrial respiratory chain in the inner mitochondrial membrane. Supporting our in vitro experiments, a yeast model of PD shows that α-syn toxicity in yeast depends on VDAC. The functional interactions between VDAC and α-syn, revealed by the present study, point toward the long sought after physiological and pathophysiological roles for monomeric α-syn in PD and in other α-synucleinopathies.
Associations Between Diabetes Mellitus and Neurodegenerative Diseases.
Szablewski L Int J Mol Sci. 2025; 26(2).
PMID: 39859258 PMC: 11765393. DOI: 10.3390/ijms26020542.
VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration.
Argueti-Ostrovsky S, Barel S, Kahn J, Israelson A Biomolecules. 2025; 15(1).
PMID: 39858428 PMC: 11762377. DOI: 10.3390/biom15010033.
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.
Ribaric S Int J Mol Sci. 2024; 25(8).
PMID: 38673943 PMC: 11050090. DOI: 10.3390/ijms25084358.
Sarkar D, Bhunia A ACS Bio Med Chem Au. 2024; 4(1):4-19.
PMID: 38404748 PMC: 10885112. DOI: 10.1021/acsbiomedchemau.3c00055.
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease.
Saramowicz K, Siwecka N, Galita G, Kucharska-Lusina A, Rozpedek-Kaminska W, Majsterek I Int J Mol Sci. 2024; 25(1).
PMID: 38203531 PMC: 10778752. DOI: 10.3390/ijms25010360.